Skip to main content
LAB $0.63 +2.82%
LAB logo
LAB · Standard Biotools Inc.
Track LAB — free
$0.63 +0.02 (+2.82%) At close · Nov 20 Q1 2025 earnings call transcript
Market Cap
$249.11M
Shares
394.79M
Volume · Nov 20 2.81M Avg daily vol (3M) 1.2M
All webcasts

Earnings call · FY2025 Q2

Standard Biotools Inc. (LAB) Q2 2025 Earnings Call

Concluded Aug 11, 2025
Aug 11, 2025
Period
FY2025 Q2
Runtime
—
Sources
2 artifacts
Revenue $21.76M -3.2% YoY
Diluted EPS -$0.09
Gross margin 48.8% +2.7 pp YoY
Net income -$33.46M
Open full screen 8-K 10-Q

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.

Forward guidance

2 guided metrics

Management's latest ranges and targets are included below.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Research materials

Open the source you need; every reader stays inside this workspace.

Forward guidance

From the 8-K filed Aug 11, 2025.

Metric Guided
Combined revenue
fiscal year 2025
$165M – $175M
Revenue from continuing operations
fiscal year 2025
$78M – $83M

Quarter detail

How the reported period landed and where the business moved.

Revenue · products & services

Consumables$10.46M +18.2% YoY
Services and Other Revenue$6.09M -7.7% YoY
Instruments$5.21M -26% YoY
Full-screen source Call document